SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Opexa Therapeutics, Inc. – ‘8-K’ for 6/30/17

On:  Monday, 7/3/17, at 6:10am ET   ·   For:  6/30/17   ·   Accession #:  1193125-17-220580   ·   File #:  1-33004

Previous ‘8-K’:  ‘8-K’ on / for 5/22/17   ·   Next:  ‘8-K’ on 7/19/17 for 7/18/17   ·   Latest:  ‘8-K’ on 11/20/23 for 11/17/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 7/03/17  Opexa Therapeutics, Inc.          8-K:1,8,9   6/30/17    5:728K                                   Donnelley … Solutions/FA

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     27K 
 2: EX-2.1      Plan of Acquisition, Reorganization, Arrangement,   HTML    427K 
                          Liquidation or Succession                              
 3: EX-2.2      Plan of Acquisition, Reorganization, Arrangement,   HTML     39K 
                          Liquidation or Succession                              
 4: EX-2.3      Plan of Acquisition, Reorganization, Arrangement,   HTML     40K 
                          Liquidation or Succession                              
 5: EX-99.1     Miscellaneous Exhibit                               HTML     19K 




        
Filing Submission 0001193125-17-220580 – SGML Text

Original SGML Text submitted by:  Donnelley Financial Solutions/FA  (as Filing Agent) 

To view the SGML, please refresh
Refresh emoji
this page.


Top

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 8, 9:41:25.2am ET